Virtus ETF Advisers’s LifeMD LFMD Stock Holding History

Virtus ETF Advisers’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,274	Closed	-$167K	–	496
2025 Q2	$167K	Sell	12,274 -26,912	-69%	-$254K	0.1%	226
2025 Q1	$213K	Buy	+39,186	New	+$222K	0.14%	200

Other funds holding LFMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtus ETF Advisers's LFMD Position: Q3 2025 in Review

Virtus ETF Advisers sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 12,274 shares — an estimated $167K sold.

Virtus ETF Advisers first reported a position in LFMD in Q1 2025 and held it in 2 quarters. The position peaked at $213K in Q1 2025. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

Virtus ETF Advisers reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
Virtus ETF Advisers sold 12,274 LifeMD shares in Q3 2025, an estimated $167K.
Virtus ETF Advisers first reported a position in LifeMD in Q1 2025 and held it in 2 quarters.
Virtus ETF Advisers's LifeMD position peaked at $213K in Q1 2025.
114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Virtus ETF Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.